Advertisement

Topics

GENFIT Company Profile

09:45 EDT 18th June 2018 | BioPortfolio

GENFIT (Paris:ALGFT) is a biopharmaceutical company focused on the Discovery and Development of drug candidates in strategic therapeutic fields linked to cardiometabolic and neurodegenerative disorders (prediabetes/diabetes, atherosclerosis, dyslipidemia, obesity, Alzheimer’s…). GENFIT uses a multi-pronged approach based on early diagnosis, preventive solutions, and therapeutic treatments to address these major public health concerns and their unmet medical needs. GENFIT’s proprietary research programs and its partnerships with leading pharmaceutical companies, including SANOFI-AVENTIS, SOLVAY GROUP, and SERVIER, have resulted in the creation of a rich and diversified pipeline of drug candidates at different stages of development. GENFIT’s lead proprietary compound, GFT505, is currently in Phase II and two other compounds, in partnership with SANOFI-AVENTIS and SOLVAY, are in the advanced stages of Phase I.

Location

Parc Eurasanté – Lille Métropole
885, avenue Eugène Avinée
LOOS
59120
France

Contact

Phone: +33 (0)3 20 16 40 00
Fax: +33 (0)3 20 16 40 01
Email: contact@genfit.com


News Articles [13 Associated News Articles listed on BioPortfolio]

NASH Leader goes Pediatric with Clinical Trial Launch in US

The FDA has cleared Genfit to kick off clinical trials to see if its NASH drug, elafibranor, can also help children. Genfit develops diagnostic and therapeutic tools for metabolic and inflammatory d...

GENFIT: Publication of the 2017 Registration Document

GENFIT: PUBLICATION OF THE 2017 REGISTRATION DOCUMENT Lille (France), Cambridge (Massachusetts, United States), April 27, 2018 - GENFIT (Euronext: GNFT - ISIN: FR0004163111), a biophar...

GENFIT : ANNOUNCES ITS FINANCIAL CALENDAR FOR 2018

GENFIT:  ANNOUNCES ITS FINANCIAL CALENDAR FOR 2018 Lille (France), Cambridge (Massachusetts, United States), January 12, 2018 - GENFIT (Euronext: GNFT - ISIN: FR0004163111), a biopha...

GENFIT: First quarter 2018 financial information

GENFIT: First quarter 2018 financial information (Unaudited financial information under IFRS) Cash and cash equivalents of €255.2 million at March 31, 2018  Revenues for the fi...

GENFIT : ORDINARY AND EXTRAORDINARY SHAREHOLDERS' MEETING OF JUNE 15, 2018 - AVAILABILITY OF PREPARATORY DOCUMENTS

GENFIT: ordinary and extraordinary SHAREHOLDERS' meeting of june 15, 2018 - AVAILABILITY OF PREPARATORY DOCUMENTS Lille (France), Cambridge (Massachusetts, United States), May 9, 2...

GENFIT: Announces the Nomination of Pascal Prigent as Executive Vice President Marketing and Commercial Development

GENFIT: Announces the Nomination of Pascal Prigent as Executive Vice President Marketing and Commercial Development Lille (France), Cambridge (Massachusetts, United States), May 31, ...

Genfit SA GNFT Financial and Strategic SWOT Analysis Review [Report Updated: 09032018] Prices from USD $300

SummaryGenfit SA Genfit is a biopharmaceutical company that develops therapeutic and diagnostic solutions for metabolic and inflammatory diseases in liver and gastroenterology diseases. The company's ...

GENFIT : Positive Outcome from the 24-month Pre-Planned Safety Review by the DSMB, in RESOLVE-IT Phase 3 Clinical Trial with Elafibranor

GENFIT: Positive Outcome from the 24-month Pre-Planned Safety Review by the DSMB, in RESOLVE-IT Phase 3 Clinical Trial with Elafibranor Safety data, including adverse events and lab...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

GENFIT

GENFIT (Paris:ALGFT) is a biopharmaceutical company focused on the Discovery and Development of drug candidates in strategic therapeutic fields linked to cardiometabolic and neuro...

Bionest Partners Inc.

Bionest Partners Inc. provides strategy consulting services exclusively for the life science industries to help pharmaceutical, biopharmaceutical, diagnostics, biotechnology, and ...

More Information about "GENFIT" on BioPortfolio

We have published hundreds of GENFIT news stories on BioPortfolio along with dozens of GENFIT Clinical Trials and PubMed Articles about GENFIT for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of GENFIT Companies in our database. You can also find out about relevant GENFIT Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record